Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BICO & VITK -- Ignore unavailable to you. Want to Upgrade?

To: JK who wrote (1809)	7/9/1998 1:28:00 PM
From: Michael Kaufman	Respond to of 2395

Biocontrol Ships Diasensors to the UK PITTSBURGH, July 9 /PRNewswire/ -- Biocontrol Technology, Inc. (Nasdaq: BICO - news) announced today that pursuant to a request from its European distributor, EuroSurgical Ltd., Diasensor(R) 1000s have been shipped to the UK. This initial UK shipment will kick off the sales & distribution of the world's first non-invasive glucose sensor approved for market sales. Biocontrol learned late last week that it had been granted approval by its Notified Body, TUV Rheinland Product Safety GmbH, Cologne, Germany, to apply the CE Mark to its noninvasive glucose sensor. This allowed Biocontrol to begin shipments into the European Union (EU) and to market the noninvasive glucose sensor for diabetics almost anywhere outside of the US. George Cranstone, director of EuroSurgical, said that interest is quite high for the Diasensor and confirmed that the market for diabetic products is large in the EU as there are approximately 30 million people with diabetes. EuroSurgical and Biocontrol are implementing a plan for marketing the Diasensor in the UK, including physician training on the use of the device. Although Biocontrol's initial marketing efforts will be concentrated in the UK, other countries that have expressed an interest in the Diasensor, but were awaiting the European marketing approval, will also be pursued. Biocontrol Technology, Inc. (www.bico.com) has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products. This press release contains statements of a forward looking nature. Shareholders and potential investors are cautioned that such statements are predictions and actual events or results may vary significantly. SOURCE: Biocontrol Technology, Inc.